Northwire Canada EditionMonday, July 27, 2026
Sign inSubscribe
Northwire
⌕
URC 4.00 −4.1% BEX 0.085 +6.2% SUM 1.33 +0.8% FMN 0.270 +10.2% PHNM 0.400 +11.1% HDRO 1.11 −6.7% PWM 0.630 +0.0% LIO 0.155 +10.7% NTH 0.160 +1.6% ELEF 0.115 −8.0% DNO 0.430 +0.0% FPC 0.465 +1.1% SVRS 0.415 −2.4% CLV 0.120 +0.0% LXM 0.160 +6.7% TBK 0.305 −3.2% URC 4.00 −4.1% BEX 0.085 +6.2% SUM 1.33 +0.8% FMN 0.270 +10.2% PHNM 0.400 +11.1% HDRO 1.11 −6.7% PWM 0.630 +0.0% LIO 0.155 +10.7% NTH 0.160 +1.6% ELEF 0.115 −8.0% DNO 0.430 +0.0% FPC 0.465 +1.1% SVRS 0.415 −2.4% CLV 0.120 +0.0% LXM 0.160 +6.7% TBK 0.305 −3.2%
Financings

MiniMed to begin trading on Nasdaq Global Select Market

By The Northwire Desk — AI Analysis Mar 06, 2026 · 09:00 MMED MIND MEDICINE (MINDMED) INC.
MMED · Price

Executive Summary

  • MiniMed Group, Inc. began trading on the Nasdaq Global Select Market under ticker “MMED” following its IPO.
  • The offering was oversubscribed and ranked as the second‑largest IPO in MedTech history.
  • The transaction creates a standalone MiniMed entity and aligns with Medtronic’s strategy to focus capital on core growth opportunities.

Key Details

  • Ticker & Exchange: “MMED” on Nasdaq Global Select Market, effective March 6, 2026.
  • Offering Outcome: Oversubscribed; noted as the second‑largest IPO in MedTech history.
  • Strategic Rationale: Establishes MiniMed as an independent company for greater agility; supports Medtronic’s focus on long‑term value creation and core competencies.
  • Leadership Quote: Geoff Martha, Medtronic Chairman & CEO, highlighted the milestone, market backdrop, and strategic benefits of the spin‑out.

Notable Quotes

“Today marks an exciting milestone for both MiniMed and Medtronic… Establishing MiniMed as a standalone entity positions the company to operate with greater agility over the long term.” – Geoff Martha, Chairman & CEO, Medtronic plc

Read the original news release →